Angiogenic Factors in Endometriosis

Robert N. Taylor, Taylor RN, Dan I. Lebovic, Michael D. Mueller
Annals of the New York Academy of Sciences · 2002 · vol. 955(1) , pp. 89–100 · doi:10.1111/j.1749-6632.2002.tb02769.x · PMID:11949968 · W1975413186
review OA: closed CC0 ⤵ 251 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This review examines the cytokines, growth factors, hormones, and eicosanoids driving angiogenesis in endometriosis, suggesting interference with these factors could offer therapeutic benefits.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Similar to tumor metastases, endometriotic implants require neovascularization to establish, grow, and invade. The peritoneal environment is ideally suited to provide a proangiogenic milieu. Nevertheless, endometriotic lesions are found only in a minority of reproductive-age women (approximately 10%) with retrograde menstruation. In this paper, we review the major cytokines, growth factors, steroid hormones, and eicosanoids responsible for angiogenesis in endometriosis. We postulate that interference with angiogenic principles expressed in the peritoneum may constitute novel therapeutic opportunities for the prevention, amelioration, or treatment of pelvic endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angiogenesis Inducing Agents Endometriosis Angiogenesis Inducing Agents Ascitic Fluid Ascitic Fluid Cytokines Cytokines Endometriosis Female Humans Neovascularization, Pathologic

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (91)

Cited by (50)

Source provenance

europepmc
last seen: 2026-09-12T06:55:35.949492+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:07.520820+00:00
unpaywall
last seen: 2026-09-11T06:32:28.951138+00:00
License: CC0 · commercial use OK